Urology Times Innovation Celebration Video Series : Episode 35
Video
Urology Times 50 Innovations Series: Intracavernosal injections for erectile dysfunction
Author(s):
Video Player is loading.
Urology Times® is celebrating its 50th anniversary in 2022. To mark the occasion, we are highlighting 50 of the top innovations and developments that have transformed the field of urology over the past 50 years. In this installment, Joshua A. Broghammer, MD, discusses intracavernosal injections for the treatment of patients with erectile dysfunction. Broghammer is an associate professor of Urology at the University of Kansas Medical Center.
Related Videos
FDA testosterone labeling changes: How will they affect prescribing?
Landon Trost, MD, on the impact of the FDA labeling changes for testosterone products
How urologists can discuss testosterone labeling changes with patients
John P. Mulhall, MD, shares his reaction to the FDA’s testosterone labeling changes
An expert shares their approach to testosterone therapy in men with hypogonadism
Helen L. Bernie, DO, MPH, on the FDA’s labeling changes for testosterone products
Dayna R. Smerina and Amy M. Pearlman, MD, discuss their research in sexual medicine
Top 10 Urology Times videos of 2024
Does varicocele affect prostate cancer outcomes?
Study points to increased public interest in vaginal estrogen
Related Content
